FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116097005: Pioglitazone hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177441010 Pioglitazone hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674916012 Pioglitazone hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177441010 Pioglitazone hydrochloride en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
177441010 Pioglitazone hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674916012 Pioglitazone hydrochloride (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
674916012 Pioglitazone hydrochloride (substance) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core
674916012 Pioglitazone hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
18441000188118 pioglitazone chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
833671000172112 chlorhydrate de pioglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
18441000188118 pioglitazone chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
833671000172112 chlorhydrate de pioglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pioglitazone hydrochloride Is a Thiazolidinedione (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride Is a Thiazolidinedione (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride Is a Pioglitazone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride Has disposition Peroxisome proliferator-activated gamma receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride Is modification of (attribute) Pioglitazone (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet Has precise active ingredient False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has precise active ingredient False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet Has precise active ingredient False Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet Has precise active ingredient True Pioglitazone hydrochloride Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start